CTD Holdings Submits Application for Listing on NASDAQ
12 juin 2019 12h53 HE
|
CTD Holdings, Inc.
ALACHUA, FL, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the...
CTD Holdings Announces Grant to U.S. Non-Profit Organization to Support Patient Participation in Informational Meetings with Regulators
28 févr. 2019 10h00 HE
|
CTD Holdings, Inc.
Support is part of CTD’s efforts to recognize Rare Disease Day 2019 ALACHUA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that...
CTD Announces Appointment of Sharon H. Hrynkow, PhD as Chief Scientific Officer
15 févr. 2019 10h04 HE
|
CTD Holdings, Inc.
ALACHUA, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Patients with Niemann-Pick Disease Type C
07 févr. 2019 08h00 HE
|
CTD Holdings, Inc.
ALACHUA, Fla., Feb. 07, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Announces Partnership with United BioSource LLC (UBC) to support the Extension Protocol for its Phase I Clinical Trial in the United States
18 janv. 2019 08h00 HE
|
CTD Holdings, Inc.
ALACHUA, Fla., Jan. 18, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Announces Presentation at Upcoming Conference on Lysosomal Storage Diseases
10 janv. 2019 08h00 HE
|
CTD Holdings, Inc.
Annual conference offers opportunities for academic researchers and industry representatives to exchange information on novel therapeutic interventions ALACHUA, Fla., Jan. 10, 2019 (GLOBE NEWSWIRE)...
CTD Holdings’ Senior VP for Medical Affairs Appointed to Committee of the National Academies of Sciences, Engineering, and Medicine
08 janv. 2019 08h52 HE
|
CTD Holdings, Inc.
ALACHUA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Holdings Closes $2.0 Million Private Placement
21 déc. 2018 08h00 HE
|
CTD Holdings, Inc.
ALACHUA, Fla., Dec. 21, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Holdings to Present at WORLD Symposium on Lysosomal Storage Diseases
12 déc. 2018 08h00 HE
|
CTD Holdings, Inc.
ALACHUA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Holdings to Present at Brains for Brain Conference on Lysosomal Storage Diseases
10 déc. 2018 09h11 HE
|
CTD Holdings, Inc.
ALACHUA, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...